Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for GKOS

Stock Name	Glaukos Corp
Ticker	GKOS(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US3773221029
LEI	5299004JA1LHE21M6T14

Show aggregate GKOS holdings

News associated with GKOS

Zacks Research Weighs in on Glaukos’ Q3 Earnings (NYSE:GKOS): Glaukos Corporation (NYSE:GKOS – Free Report) – Investment analysts at Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for Glaukos in a note issued to investors on Wednesday, August 20th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings per share of $0.02 for the quarter, down […] - 2025-08-25 03:02:49
Vanguard Group Inc. Has $587.09 Million Holdings in Glaukos Corporation (NYSE:GKOS): Vanguard Group Inc. lowered its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 0.2% in the first quarter, Holdings Channel.com reports. The institutional investor owned 5,965,115 shares of the medical instruments supplier’s stock after selling 9,856 shares during the quarter. Vanguard Group Inc. owned approximately 0.10% of Glaukos worth $587,087,000 as of its most […] - 2025-08-14 04:37:10
Natixis Advisors LLC Cuts Stock Position in Glaukos Corporation (NYSE:GKOS): Natixis Advisors LLC lowered its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 12.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,871 shares of the medical instruments supplier’s stock after selling 4,428 shares during the quarter. Natixis […] - 2025-08-07 04:49:06
Thornburg Investment Management Inc. Has $4.96 Million Stake in Glaukos Corporation (NYSE:GKOS): Thornburg Investment Management Inc. increased its stake in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 10.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 50,430 shares of the medical instruments supplier’s stock after acquiring an additional 4,847 shares during the period. Thornburg […] - 2025-07-30 04:58:52
KLP Kapitalforvaltning AS Has $1.07 Million Stock Position in Glaukos Corporation (NYSE:GKOS): KLP Kapitalforvaltning AS lessened its stake in Glaukos Corporation (NYSE:GKOS – Free Report) by 4.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,900 shares of the medical instruments supplier’s stock after selling 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings […] - 2025-07-29 05:27:00
4,853 Shares in Glaukos Corporation (NYSE:GKOS) Acquired by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd acquired a new position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 4,853 shares of the medical instruments supplier’s stock, valued at approximately $478,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of […] - 2025-07-28 08:10:46
Envestnet Asset Management Inc. Decreases Holdings in Glaukos Corporation (NYSE:GKOS): Envestnet Asset Management Inc. decreased its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 27.8% during the 1st quarter, Holdings Channel.com reports. The fund owned 28,038 shares of the medical instruments supplier’s stock after selling 10,817 shares during the period. Envestnet Asset Management Inc.’s holdings in Glaukos were worth $2,760,000 at the […] - 2025-07-28 04:28:50
Glaukos Corporation (NYSE:GKOS) Shares Acquired by Victory Capital Management Inc.: Victory Capital Management Inc. lifted its holdings in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 88.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 140,411 shares of the medical instruments supplier’s stock after buying an additional 66,009 shares during the period. Victory Capital […] - 2025-07-24 05:00:46
4,146 Shares in Glaukos Corporation (NYSE:GKOS) Purchased by OneAscent Financial Services LLC: OneAscent Financial Services LLC bought a new position in Glaukos Corporation (NYSE:GKOS – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,146 shares of the medical instruments supplier’s stock, valued at approximately $408,000. A number of other hedge funds also recently […] - 2025-07-23 06:45:09
Mutual of America Capital Management LLC Sells 324 Shares of Glaukos Corporation (NYSE:GKOS): Mutual of America Capital Management LLC decreased its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,029 shares of the medical instruments supplier’s stock after selling 324 shares during the period. Mutual of […] - 2025-07-22 07:06:53
Glaukos Corporation (NYSE:GKOS) Shares Acquired by Avior Wealth Management LLC: Avior Wealth Management LLC boosted its position in Glaukos Corporation (NYSE:GKOS – Free Report) by 30.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,384 shares of the medical instruments supplier’s stock after buying an additional 782 shares during the quarter. […] - 2025-06-23 05:51:04
Glaukos Corporation (NYSE:GKOS) Stake Trimmed by Trust Point Inc.: Trust Point Inc. cut its position in shares of Glaukos Corporation (NYSE:GKOS – Free Report) by 53.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,999 shares of the medical instruments supplier’s stock after selling 3,481 shares during the quarter. Trust Point Inc.’s […] - 2025-06-18 05:52:52
Glaukos Corporation (NYSE:GKOS) Receives Consensus Rating of “Moderate Buy” from Analysts: Glaukos Corporation (NYSE:GKOS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have assigned a buy recommendation to the […] - 2025-06-18 02:52:53
Versant Capital Management Inc Purchases 327 Shares of Glaukos Co. (NYSE:GKOS): Versant Capital Management Inc boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 583.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 383 shares of the medical instruments supplier’s stock after acquiring an additional 327 shares during the period. Versant Capital Management Inc’s holdings in Glaukos were worth […] - 2025-06-06 05:44:58
Cetera Investment Advisers Reduces Stock Position in Glaukos Co. (NYSE:GKOS): Cetera Investment Advisers lessened its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 46.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,504 shares of the medical instruments supplier’s stock after selling 1,309 shares during the quarter. Cetera Investment Advisers’ holdings in Glaukos were worth $226,000 as of its most recent SEC […] - 2025-06-02 04:34:59
Royal Bank of Canada Cuts Stake in Glaukos Co. (NYSE:GKOS): Royal Bank of Canada reduced its position in Glaukos Co. (NYSE:GKOS – Free Report) by 41.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 112,310 shares of the medical instruments supplier’s stock after selling 79,841 shares during the quarter. Royal Bank of […] - 2025-05-26 05:27:10
Focus Partners Wealth Invests $379,000 in Glaukos Co. (NYSE:GKOS): Focus Partners Wealth purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 2,528 shares of the medical instruments supplier’s stock, valued at approximately $379,000. Other large investors have also modified their holdings of the company. Rhumbline Advisers raised its stake in […] - 2025-05-22 05:08:53
Analysts See 18% Gains Ahead For USVM: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-20 07:56:36
Glaukos (NYSE:GKOS) Given New $72.00 Price Target at Morgan Stanley: Glaukos (NYSE:GKOS – Get Free Report) had its price objective decreased by stock analysts at Morgan Stanley from $110.00 to $72.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “underweight” rating on the medical instruments supplier’s stock. Morgan Stanley’s price objective suggests a potential downside of 18.40% from the company’s current […] - 2025-05-08 05:00:57
Mariner LLC Sells 783 Shares of Glaukos Co. (NYSE:GKOS): Mariner LLC cut its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 11.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,249 shares of the medical instruments supplier’s stock after selling 783 shares during the period. Mariner […] - 2025-04-28 05:08:52
Barclays PLC Acquires 2,086 Shares of Glaukos Co. (NYSE:GKOS): Barclays PLC lifted its holdings in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,785 shares of the medical instruments supplier’s stock after purchasing an additional 2,086 shares during the quarter. Barclays PLC’s holdings […] - 2025-04-21 05:38:46
Raymond James Financial Inc. Acquires Shares of 112,771 Glaukos Co. (NYSE:GKOS): Raymond James Financial Inc. bought a new position in Glaukos Co. (NYSE:GKOS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 112,771 shares of the medical instruments supplier’s stock, valued at approximately $16,910,000. Several other institutional investors […] - 2025-04-21 04:40:47
Schroder Investment Management Group Acquires 6,991 Shares of Glaukos Co. (NYSE:GKOS): Schroder Investment Management Group grew its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 213.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,259 shares of the medical instruments supplier’s stock after purchasing an additional 6,991 shares during […] - 2025-04-07 05:12:52
Pictet Asset Management Holding SA Purchases 1,041 Shares of Glaukos Co. (NYSE:GKOS): Pictet Asset Management Holding SA lifted its position in Glaukos Co. (NYSE:GKOS – Free Report) by 15.9% in the 4th quarter, Holdings Channel.com reports. The fund owned 7,582 shares of the medical instruments supplier’s stock after acquiring an additional 1,041 shares during the period. Pictet Asset Management Holding SA’s holdings in Glaukos were worth $1,137,000 […] - 2025-04-06 06:25:02
Norges Bank Takes Position in Glaukos Co. (NYSE:GKOS): Norges Bank purchased a new position in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 563,493 shares of the medical instruments supplier’s stock, valued at approximately $84,490,000. A number of other hedge funds […] - 2025-04-03 05:36:55
Glaukos Co. (NYSE:GKOS) Stock Position Lowered by Corebridge Financial Inc.: Corebridge Financial Inc. decreased its position in Glaukos Co. (NYSE:GKOS – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 26,274 shares of the medical instruments supplier’s stock after selling 2,051 shares during the period. Corebridge Financial Inc.’s holdings in Glaukos were worth […] - 2025-03-31 05:49:01
Congress Wealth Management LLC DE Sells 400 Shares of Glaukos Co. (NYSE:GKOS): Congress Wealth Management LLC DE reduced its stake in Glaukos Co. (NYSE:GKOS – Free Report) by 22.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,389 shares of the medical instruments supplier’s stock after selling 400 shares during the period. […] - 2025-03-31 05:14:58
Glaukos Co. (NYSE:GKOS) Shares Bought by Xponance Inc.: Xponance Inc. boosted its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 13.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,633 shares of the medical instruments supplier’s stock after buying an additional 426 shares during the quarter. Xponance Inc.’s […] - 2025-03-26 05:56:54
Sequoia Financial Advisors LLC Trims Stock Holdings in Glaukos Co. (NYSE:GKOS): Sequoia Financial Advisors LLC lowered its holdings in Glaukos Co. (NYSE:GKOS – Free Report) by 6.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,773 shares of the medical instruments supplier’s stock after selling 117 shares during the period. Sequoia Financial Advisors LLC’s holdings in […] - 2025-03-20 06:40:56
Analysts Set Glaukos Co. (NYSE:GKOS) Price Target at $163.25: Glaukos Co. (NYSE:GKOS – Get Free Report) has earned an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-03-13 04:06:47

iShares US Medical Devices UCITS ETF GKOS holdings

Date	Number of GKOS Shares Held	Base Market Value of GKOS Shares	Local Market Value of GKOS Shares	Change in GKOS Shares Held	Change in GKOS Base Value	Current Price per GKOS Share Held	Previous Price per GKOS Share Held
2025-09-25 (Thursday)	8,069	USD 657,381	USD 657,381
2025-09-24 (Wednesday)	7,573	USD 626,969	USD 626,969
2025-09-18 (Thursday)	7,573	USD 650,066	USD 650,066	0	USD 28,323	USD 85.84	USD 82.1
2025-09-17 (Wednesday)	7,573	USD 621,743	USD 621,743	0	USD -1,894	USD 82.1	USD 82.3501
2025-09-16 (Tuesday)	7,573	USD 623,637	USD 623,637
2025-09-15 (Monday)	7,573	USD 610,687	USD 610,687
2025-09-12 (Friday)	7,573	USD 626,741	USD 626,741
2025-09-11 (Thursday)	7,573	USD 662,410	USD 662,410
2025-09-10 (Wednesday)	7,573	USD 662,789	USD 662,789

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GKOS by Blackrock for IE00BMX0DF60

Show aggregate share trades of GKOS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-06-27 SELL -124 101.420* 115.95 Profit of 14,378 on sale
2025-06-12 BUY 180 97.600* 117.04
2025-06-10 SELL -960 95.640* 117.34 Profit of 112,647 on sale
2025-06-09 SELL -1,121 94.640* 117.52 Profit of 131,736 on sale
2025-05-30 SELL -118 94.290* 118.69 Profit of 14,006 on sale
2025-05-19 BUY 59 95.850* 120.48
2025-05-09 SELL -300 89.960* 122.03 Profit of 36,610 on sale
2025-04-23 SELL -60 92.610* 125.93 Profit of 7,556 on sale
2025-04-17 SELL -60 90.260* 127.50 Profit of 7,650 on sale
2025-04-10 BUY 480 89.660* 129.59
2025-04-04 SELL -120 83.650* 131.67 Profit of 15,801 on sale
2025-04-02 SELL -120 100.040* 132.06 Profit of 15,847 on sale
2025-03-31 SELL -180 98.420* 132.92 Profit of 23,925 on sale
2025-03-19 SELL -60 101.240* 136.19 Profit of 8,172 on sale
2025-02-28 SELL -120 120.020* 142.46 Profit of 17,096 on sale
2025-02-18 BUY 125 152.960* 143.61
2025-02-05 BUY 177 157.110* 142.10
2025-02-04 BUY 236 154.320* 141.81
2025-01-29 SELL -59 159.010* 140.17 Profit of 8,270 on sale
2025-01-23 SELL -59 161.220* 137.90 Profit of 8,136 on sale
2025-01-02 SELL -118 149.680* 137.54 Profit of 16,230 on sale
2024-12-04 BUY 177 138.270* 137.48
2024-12-03 SELL -59 136.000* 137.54 Profit of 8,115 on sale
2024-12-02 SELL -708 139.080* 137.48 Profit of 97,334 on sale
2024-11-29 SELL -1,180 143.650* 137.23 Profit of 161,931 on sale
2024-11-27 SELL -177 142.690* 136.76 Profit of 24,206 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-06-27	SELL	-124	101.420*	115.95 Profit of 14,378 on sale
2025-06-12	BUY	180	97.600*	117.04
2025-06-10	SELL	-960	95.640*	117.34 Profit of 112,647 on sale
2025-06-09	SELL	-1,121	94.640*	117.52 Profit of 131,736 on sale
2025-05-30	SELL	-118	94.290*	118.69 Profit of 14,006 on sale
2025-05-19	BUY	59	95.850*	120.48
2025-05-09	SELL	-300	89.960*	122.03 Profit of 36,610 on sale
2025-04-23	SELL	-60	92.610*	125.93 Profit of 7,556 on sale
2025-04-17	SELL	-60	90.260*	127.50 Profit of 7,650 on sale
2025-04-10	BUY	480	89.660*	129.59
2025-04-04	SELL	-120	83.650*	131.67 Profit of 15,801 on sale
2025-04-02	SELL	-120	100.040*	132.06 Profit of 15,847 on sale
2025-03-31	SELL	-180	98.420*	132.92 Profit of 23,925 on sale
2025-03-19	SELL	-60	101.240*	136.19 Profit of 8,172 on sale
2025-02-28	SELL	-120	120.020*	142.46 Profit of 17,096 on sale
2025-02-18	BUY	125	152.960*	143.61
2025-02-05	BUY	177	157.110*	142.10
2025-02-04	BUY	236	154.320*	141.81
2025-01-29	SELL	-59	159.010*	140.17 Profit of 8,270 on sale
2025-01-23	SELL	-59	161.220*	137.90 Profit of 8,136 on sale
2025-01-02	SELL	-118	149.680*	137.54 Profit of 16,230 on sale
2024-12-04	BUY	177	138.270*	137.48
2024-12-03	SELL	-59	136.000*	137.54 Profit of 8,115 on sale
2024-12-02	SELL	-708	139.080*	137.48 Profit of 97,334 on sale
2024-11-29	SELL	-1,180	143.650*	137.23 Profit of 161,931 on sale
2024-11-27	SELL	-177	142.690*	136.76 Profit of 24,206 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GKOS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	155,980	0	408,297	38.2%
2025-09-18	158,440	0	317,147	50.0%
2025-09-17	145,111	0	409,200	35.5%
2025-09-16	140,208	0	407,233	34.4%
2025-09-15	142,351	113	501,810	28.4%
2025-09-12	97,763	1,000	399,810	24.5%
2025-09-11	138,884	0	237,111	58.6%
2025-09-10	124,385	0	380,164	32.7%
2025-09-09	118,497	0	281,646	42.1%
2025-09-08	123,633	0	278,178	44.4%
2025-09-05	153,553	0	305,566	50.3%
2025-09-04	232,653	0	463,856	50.2%
2025-09-03	108,703	0	229,765	47.3%
2025-09-02	81,407	0	157,566	51.7%
2025-08-29	100,573	1,790	186,144	54.0%
2025-08-28	100,902	0	223,292	45.2%
2025-08-27	65,106	0	130,268	50.0%
2025-08-26	54,432	0	202,240	26.9%
2025-08-25	70,980	13	188,332	37.7%
2025-08-22	109,440	0	232,153	47.1%
2025-08-21	60,850	0	97,646	62.3%
2025-08-20	126,239	21	249,995	50.5%
2025-08-19	162,448	0	316,943	51.3%
2025-08-18	87,807	0	204,483	42.9%
2025-08-15	115,279	729	261,975	44.0%
2025-08-14	99,733	0	220,964	45.1%
2025-08-13	169,331	0	418,521	40.5%
2025-08-12	127,458	0	359,205	35.5%
2025-08-11	130,771	0	325,915	40.1%
2025-08-08	88,140	0	336,247	26.2%
2025-08-07	165,915	132	523,296	31.7%
2025-08-06	167,710	0	438,576	38.2%
2025-08-05	194,095	0	592,603	32.8%
2025-08-04	110,453	810	315,314	35.0%
2025-08-01	246,347	2,190	708,244	34.8%
2025-07-31	853,243	1,783	2,112,188	40.4%
2025-07-30	195,473	0	991,119	19.7%
2025-07-29	119,212	299	384,793	31.0%
2025-07-28	98,629	0	352,431	28.0%
2025-07-25	50,782	0	233,956	21.7%
2025-07-24	99,823	0	508,487	19.6%
2025-07-23	55,844	0	348,407	16.0%
2025-07-22	74,546	1,897	413,022	18.0%
2025-07-21	65,768	1,964	210,651	31.2%
2025-07-18	54,629	0	208,520	26.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam